Biblio Discovery — Demo Discovery Service

48 hasil

Menampilkan 1–20 · 0,20 detik · RSS

Jurnal

Blood Global Hematology

ISSN 3050-5658 · Elsevier · 48 artikel di indeks

  1. Artikel Jurnal

    LymphGen molecular subtyping reveals therapeutic heterogeneity beyond cell-of-origin classification in Indian DLBCL

    Shrinidhi Nathany; Moin Makda; Anusha Swaminathan dkk.

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: Diffuse large B-cell lymphoma (DLBCL) is molecularly heterogeneous, yet standard cell-of-origin (COO) classification fails to capture actionable biology. Systematic genetic profiling remains unmapped in South Asian populations, who exhibit an age of onset a decade younger. We performed…

  2. Artikel Jurnal

    Epidemiology, treatment patterns, and survival of chronic myeloid leukemia in Colombia: a real-world cohort study (2018-2023)

    Jhon Bolaños-López; Natalia Prieto; Leonardo Enciso

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: The introduction of tyrosine kinase inhibitors (TKIs) has transformed chronic myeloid leukemia (CML) into a chronic condition. However, contemporary population-level data from Latin America remain scarce. We performed a retrospective, population-based cohort study including adults with…

  3. Artikel Jurnal

    Outcomes and clinical characteristics of acute promyelocytic leukemia in Kuwait: a 15-year national cohort study

    Ahmad Alhuraiji; Nermin Salem; Fatima M. Khadadah dkk.

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: Acute promyelocytic leukemia (APL) is a highly curable subtype of acute myeloid leukemia since the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), yet Middle Eastern data are limited. We report, to our knowledge, the first national APL cohort from the Arabian…

  4. Artikel Jurnal

    Health care funding and education independently predict survival in DLBCL: a large real-world study from Brazil

    Rafael Gaiolla; Guilherme Duffles; Patricia Klarmann Ziegelmann dkk.

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: In real-world settings, diffuse large B-cell lymphoma (DLBCL) outcomes may be influenced by health care system characteristics and socioeconomic factors. Brazil’s dual system includes a government-funded public system and a supplementary private sector. However, their impact on DLBCL…

  5. Artikel Jurnal

    Platelet indices as accessible biomarkers for risk stratification in pediatric sickle cell disease: a Kenyan cohort study

    Fred Abala; Eliud Njagi; Gordon Ogweno

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: Sickle cell disease (SCD) is a significant health challenge in Kenya, often associated with complications that result in 50% to 90% mortality if undiagnosed. This necessitates accessible phenotype-based biomarkers for risk stratification in resource-limited settings that offer primary…

  6. Artikel Jurnal

    Hematological malignancies in North Africa: contemporary estimates and projections for 2050

    Davidi Tawfiles; Shivaek Venkateswaran; Adrian E. Go dkk.

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: Hematological malignancies are a major contributor to cancer morbidity and mortality in North Africa, yet regional epidemiologic data remain limited. The region’s distinct demographic, sociocultural, and health care characteristics underscore the need for contemporary, country-specific…

  7. Artikel Jurnal

    Next-generation sequencing implementation in Mexican adults with acute myeloid leukemia

    Nidia K. Moncada-Saucedo; Rosario Salazar-Riojas; Yessica M. González-Martínez dkk.

    Blood Global Hematology, Vol. 2 No. 4 · 2026 · Inggris · DOAJ

    Abstract: Comprehensive genomic analysis is essential for risk stratification and therapeutic decision-making in acute myeloid leukemia (AML). However, access to next-generation sequencing (NGS) remains limited in low- and middle-income countries. We conducted a single-center prospective cohort…

  8. Artikel Jurnal

    Field evaluation of the Sickle Confirm point-of-care test for hemoglobin S and zygosity in sub-Saharan Africa

    Mor Diaw; Awa Diop; Abdou Khadir Sow dkk.

    Blood Global Hematology, Vol. 2 No. 2 · 2026 · Inggris · DOAJ

    Abstract: Sickle cell disease remains underdiagnosed in sub-Saharan Africa due to limited access to reliable, affordable, and field-adapted diagnostic tools. In this study, we aimed to independently assess the diagnostic performance of the Sickle Confirm test under routine clinical conditions in…

  9. Artikel Jurnal

    ETV6::FLT3 fusion as an unfavorable prognostic factor in an AYA patient with B-ALL

    Lucio Gatto; Jorge Arbelbide; Lucrecia Oses dkk.

    Blood Global Hematology, Vol. 2 No. 2 · 2026 · Inggris · DOAJ

    Abstract: B-cell acute lymphoblastic leukemia (B-ALL) is a genetically heterogeneous disease in which molecular characterization guides prognosis and treatment. We report, to our knowledge, the first known case of B-ALL in an adolescent and young adult patient harboring an ETV6::FLT3 fusion. A…

  10. Artikel Jurnal

    Clinical practice guidelines for the diagnosis and management of Hodgkin lymphoma in countries with restricted resources

    Raheel Iftikhar; Mussavir Hussain Bangash; Ali Bazarbachi dkk.

    Blood Global Hematology, Vol. 2 No. 2 · 2026 · Inggris · DOAJ

    Background: Classical Hodgkin lymphoma (cHL) is a highly curable malignancy but presents a significant health challenge in low- to middle-income countries (LMICs), where resource constraints, lack of novel therapies, and advanced diagnostics hinder effective treatments, particularly in relapsed…

  11. Artikel Jurnal

    Twenty-five years of tyrosine kinase inhibitors for chronic myeloid leukemia in Brazil

    Claudia Astigarraga; Ana Paula Beck da Silva Etges; Carisi Anne Polanczyk

    Blood Global Hematology, Vol. 2 No. 2 · 2026 · Inggris · DOAJ

    Abstract: Twenty-five years ago tyrosine kinase inhibitors (TKIs) revolutionized treatment by significantly improving survival and transforming chronic myeloid leukemia (CML) into a controllable chronic condition for many patients. It marked the beginning of a new era in oncology, representing the…

  12. Artikel Jurnal

    Clinical outcomes of patients with chronic myeloid leukemia with asciminib provided by a compassionate program in Brazil

    Katia Pagnano; Isabela Siqueira; Giulia de Campos dkk.

    Blood Global Hematology, Vol. 1 No. 3 · 2025 · Inggris · DOAJ

    Abstract: This study evaluated the clinical outcomes of patients with chronic myeloid leukemia (CML) treated with asciminib, a first-in-class allosteric inhibitor that selectively targets the ABL myristoyl pocket (STAMP) of BCR::ABL1. Through Novartis’s Managed Access Program in Brazil, asciminib…

  13. Artikel Jurnal

    Development of disease-specific growth curves from Kenyan children with sickle cell anemia

    George A. Tomlinson; Philippe Backeljauw; George Mochamah dkk.

    Blood Global Hematology, Vol. 1 No. 3 · 2025 · Inggris · DOAJ

    Abstract: Sickle cell anemia (SCA) is a life-threatening hemoglobinopathy with worldwide distribution. Featuring multiple acute and chronic complications, SCA is also associated with growth impairment. A lack of appropriate reference data on height, weight, and body mass index (BMI) impedes…

  14. Artikel Jurnal

    From donor to diagnosis: using blood banks to estimate MGUS prevalence in a Mexican population

    Carlos de la Cruz-de la Cruz; Jorge Alberto Zamayoa Torres; Odra Martínez González dkk.

    Blood Global Hematology, Vol. 1 No. 3 · 2025 · Inggris · DOAJ

    Abstract: Monoclonal gammopathy of undetermined significance (MGUS) is a common plasma cell disorder and precursor to multiple myeloma (MM). While MGUS precedes nearly all MM cases, most individuals remain stable without progression. Its prevalence varies by age, sex, and ethnicity, with lower…

  15. Artikel Jurnal

    Neurocognitive functioning of patients with sickle cell disease in low- and middle-income countries

    Bari Pinkett; Katherine Nesbitt; Evan Rooney dkk.

    Blood Global Hematology, Vol. 1 No. 3 · 2025 · Inggris · DOAJ

    Abstract: Sickle cell disease (SCD) is a monogenic blood disorder that affects the production of hemoglobin. Patients with SCD display slowed neurocognitive development resulting from a combination of cerebrovascular complications and sociodemographic factors. In low- and middle-income countries…

  16. Artikel Jurnal

    Circulating plasma EBV DNA: a potential tool to facilitate diagnosis of pediatric Burkitt lymphoma in sub-Saharan Africa

    Karena Volesky-Avellaneda; Rena R. Xian; Todd B. Young dkk.

    Blood Global Hematology, Vol. 1 No. 3 · 2025 · Inggris · DOAJ

    Abstract: In sub-Saharan Africa (SSA), many pediatric patients with Burkitt lymphoma (BL) perish because of diagnostic delays. About 95% of pediatric BL cases in SSA are Epstein-Barr virus (EBV) positive. We assessed plasma EBV DNA in 400 pediatric patients with BL and 400 controls…